Achieve Life Sciences Q2 2024 GAAP EPS $(0.25) Misses $(0.23) Estimate
Portfolio Pulse from Benzinga Newsdesk
Achieve Life Sciences (NASDAQ:ACHV) reported a Q2 2024 GAAP EPS of $(0.25), missing the analyst consensus estimate of $(0.23) by 8.7%.
August 13, 2024 | 8:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Achieve Life Sciences reported a Q2 2024 GAAP EPS of $(0.25), missing the analyst consensus estimate of $(0.23) by 8.7%. This earnings miss could lead to a negative short-term impact on the stock price.
The earnings miss indicates that the company's performance was below market expectations, which typically results in a negative reaction from investors and a potential decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100